These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24379282)

  • 41. Improved Protection in a Rabbit Model of Community-Associated Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia upon Neutralization of Leukocidins in Addition to Alpha-Hemolysin.
    Diep BA; Le VT; Visram ZC; Rouha H; Stulik L; Dip EC; Nagy G; Nagy E
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6333-40. PubMed ID: 27527081
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting leukocidin-mediated immune evasion protects mice from Staphylococcus aureus bacteremia.
    Tam K; Lacey KA; Devlin JC; Coffre M; Sommerfield A; Chan R; O'Malley A; Koralov SB; Loke P; Torres VJ
    J Exp Med; 2020 Sep; 217(9):. PubMed ID: 32602902
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel human monoclonal antibodies targeting the F subunit of leukocidins reduce disease progression and mortality caused by Staphylococcus aureus.
    Jing C; Liu C; Liu F; Gao Y; Liu Y; Guan Z; Xuan B; Yu Y; Yang G
    BMC Microbiol; 2018 Nov; 18(1):181. PubMed ID: 30419818
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibody responses in patients with staphylococcal septicemia against two Staphylococcus aureus fibrinogen binding proteins: clumping factor and an extracellular fibrinogen binding protein.
    Colque-Navarro P; Palma M; Söderquist B; Flock JI; Möllby R
    Clin Diagn Lab Immunol; 2000 Jan; 7(1):14-20. PubMed ID: 10618270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preventing lung pathology and mortality in rabbit Staphylococcus aureus pneumonia models with cytotoxin-neutralizing monoclonal IgGs penetrating the epithelial lining fluid.
    Stulik L; Rouha H; Labrousse D; Visram ZC; Badarau A; Maierhofer B; Groß K; Weber S; Kramarić MD; Glojnarić I; Nagy G; Croisier D; Nagy E
    Sci Rep; 2019 Mar; 9(1):5339. PubMed ID: 30926865
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum antibodies against Panton-Valentine leukocidin in a normal population and during Staphylococcus aureus infection.
    Croze M; Dauwalder O; Dumitrescu O; Badiou C; Gillet Y; Genestier AL; Vandenesch F; Etienne J; Lina G
    Clin Microbiol Infect; 2009 Feb; 15(2):144-8. PubMed ID: 19154491
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Context matters: The importance of dimerization-induced conformation of the LukGH leukocidin of Staphylococcus aureus for the generation of neutralizing antibodies.
    Badarau A; Rouha H; Malafa S; Battles MB; Walker L; Nielson N; Dolezilkova I; Teubenbacher A; Banerjee S; Maierhofer B; Weber S; Stulik L; Logan DT; Welin M; Mirkina I; Pleban C; Zauner G; Gross K; Jägerhofer M; Magyarics Z; Nagy E
    MAbs; 2016 Oct; 8(7):1347-1360. PubMed ID: 27467113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic variation of staphylococcal LukAB toxin determines receptor tropism.
    Perelman SS; James DBA; Boguslawski KM; Nelson CW; Ilmain JK; Zwack EE; Prescott RA; Mohamed A; Tam K; Chan R; Narechania A; Pawline MB; Vozhilla N; Moustafa AM; Kim SY; Dittmann M; Ekiert DC; Bhabha G; Shopsin B; Planet PJ; Koralov SB; Torres VJ
    Nat Microbiol; 2021 Jun; 6(6):731-745. PubMed ID: 33875847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nasopharyngeal colonization elicits antibody responses to staphylococcal and pneumococcal proteins that are not associated with a reduced risk of subsequent carriage.
    Prevaes SM; van Wamel WJ; de Vogel CP; Veenhoven RH; van Gils EJ; van Belkum A; Sanders EA; Bogaert D
    Infect Immun; 2012 Jun; 80(6):2186-93. PubMed ID: 22451514
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of biologic agents to neutralize the bicomponent leukocidins of
    Chan R; Buckley PT; O'Malley A; Sause WE; Alonzo F; Lubkin A; Boguslawski KM; Payne A; Fernandez J; Strohl WR; Whitaker B; Lynch AS; Torres VJ
    Sci Transl Med; 2019 Jan; 11(475):. PubMed ID: 30651319
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Diagnostic Serum Antibody Test for Patients With Staphylococcus aureus Osteomyelitis.
    Nishitani K; Beck CA; Rosenberg AF; Kates SL; Schwarz EM; Daiss JL
    Clin Orthop Relat Res; 2015 Sep; 473(9):2735-49. PubMed ID: 26013151
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection.
    Yoong P; Pier GB
    Proc Natl Acad Sci U S A; 2010 Feb; 107(5):2241-6. PubMed ID: 20133867
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retrospective Identification of a Broad IgG Repertoire Differentiating Patients With
    Rigat F; Bartolini E; Dalsass M; Kumar N; Marchi S; Speziale P; Maione D; Chen L; Romano MR; Alegre ML; Bagnoli F; Daum RS; David MZ
    Front Immunol; 2019; 10():114. PubMed ID: 30792711
    [No Abstract]   [Full Text] [Related]  

  • 54. Characterization of the humoral immune response during Staphylococcus aureus bacteremia and global gene expression by Staphylococcus aureus in human blood.
    den Reijer PM; Lemmens-den Toom N; Kant S; Snijders SV; Boelens H; Tavakol M; Verkaik NJ; van Belkum A; Verbrugh HA; van Wamel WJ
    PLoS One; 2013; 8(1):e53391. PubMed ID: 23308212
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo mapping of a protective linear neutralizing epitope at the N-terminus of alpha hemolysin from Staphylococcus aureus.
    Oscherwitz J; Muñoz-Planillo R; Yu F; Núñez G; Cease KB
    Mol Immunol; 2014 Jul; 60(1):62-71. PubMed ID: 24769493
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-glucosaminidase IgG in sera as a biomarker of host immunity against Staphylococcus aureus in orthopaedic surgery patients.
    Gedbjerg N; LaRosa R; Hunter JG; Varrone JJ; Kates SL; Schwarz EM; Daiss JL
    J Bone Joint Surg Am; 2013 Nov; 95(22):e171. PubMed ID: 24257671
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients.
    Dryla A; Prustomersky S; Gelbmann D; Hanner M; Bettinger E; Kocsis B; Kustos T; Henics T; Meinke A; Nagy E
    Clin Diagn Lab Immunol; 2005 Mar; 12(3):387-98. PubMed ID: 15753252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Counter inhibition between leukotoxins attenuates Staphylococcus aureus virulence.
    Yoong P; Torres VJ
    Nat Commun; 2015 Sep; 6():8125. PubMed ID: 26330208
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis.
    Dumont AL; Nygaard TK; Watkins RL; Smith A; Kozhaya L; Kreiswirth BN; Shopsin B; Unutmaz D; Voyich JM; Torres VJ
    Mol Microbiol; 2011 Feb; 79(3):814-25. PubMed ID: 21255120
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of infecting strains and superantigen-neutralizing antibodies in Staphylococcus aureus bacteremia.
    Grumann D; Ruotsalainen E; Kolata J; Kuusela P; Järvinen A; Kontinen VP; Bröker BM; Holtfreter S
    Clin Vaccine Immunol; 2011 Mar; 18(3):487-93. PubMed ID: 21248153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.